Koya Medical Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms
Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active compression therapy system for lymphedema—Dayspring™— was issued new billing codes by the Center of Medicare & Medicaid Services (CMS) in accordance with the Healthcare Common Procedure Coding System (HCPCS). Read More →
Mobility-Enabled Compression Device for Lymphedema: Interview with CEO of Koya Medical
Koya Medical, a medtech company based in California, has developed the Dayspring active compression system for the treatment of lymphedema. Read More →
Koya Medical Closes $11M Financing to Accelerate Treatment for Lymphedema and Venous Disorders
Koya Medical (www.koyamedical.com), a healthcare company focused on treating lymphedema and vein disease, today announced the close of a $11 million Series A investment round. The new investment was led by Arboretum Ventures. Read More →